Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Cancer Pain 2Squamous Cell Carcinoma of Head and Neck 1Opioid-Related Disorders 1Neoplasms 1Mucositis 1Lymphoma, Follicular 1Chronic Pain 1

Interventions

Morphine 7Ketamine 5Fentanyl 4Sodium Chloride 3Saline Solution 3Lidocaine 3Educational Status 3Dexmedetomidine 3Cognitive Behavioral Therapy 3Anesthetics, Local 3Surveys and Questionnaires 2Pregabalin 2Mindfulness-Based Stress Reduction 2Hypnosis 2Bupivacaine 2Botulinum Toxins, Type A 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tianeptine 1siltuximab 1onabotulinum toxin A 1nabiximols 1morphine, naltrexone combination 1erenumab 1Yoga 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1Tramadol 1Therapeutics 1Telemedicine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chronic Pain × Buprenorphine × Clear all
NCT00916890 2014-01-09

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 4 Suspended
320 enrolled

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡